CHARLOTTESVILLE, Va., Oct. 2, 2025 /PRNewswire/ — RIVANNA®, developers of world-first imaging-based medical technologies, today announced it has been named a finalist in MedTech Innovator’s (MTI) 2025 Early-Stage Grand Prize competition. The recognition comes as part of the culmination of the world’s largest accelerator of medical technology companies.
As a finalist, RIVANNA will receive $25,000 in non-dilutive funding and compete for the top honor of the Early-Stage Grand Prize of $350,000 at The MedTech Conference, October 5–8, 2025, in San Diego, Calif. During the finals, the company will pitch its innovation, Accuro® 3S, the first AI-enabled ultrasound guidance system designed to extend ultrasound-guided regional anesthesia to procedures such as epidurals and spinal blocks, to a panel of industry experts and a live audience that will vote in real time to select the winner.
“It is an incredible honor to be selected as a finalist in MedTech Innovator’s 2025 Early-Stage Grand Prize competition,” said Will Mauldin, Co-founder and CEO at RIVANNA. “This recognition not only validates the progress we have made in advancing Accuro 3S but also supports our mission to develop and commercialize world-first, imaging-based medical technologies that elevate global standards of care.”
In 2025, MTI selected 64 companies from nearly 1,500 global applicants for its highly competitive accelerator cohort, representing the top 4% of innovations worldwide. Companies benefit from MTI’s comprehensive program of mentorship, strategic guidance, and access to an unparalleled network of medtech manufacturers, investors, providers, and payers.
For more information about RIVANNA, visit rivannamedical.com.
About RIVANNA
RIVANNA is a commercial-stage medical device innovator and manufacturer based in Charlottesville, VA. RIVANNA develops and commercializes world-first, imaging-based medical technologies that elevate global standards of care. The company provides early and late-stage comprehensive imaging solutions for point-of-care spinal needle interventions and musculoskeletal diagnostics.
About MedTech Innovator
MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing nearly 14,000 applicants and fostering the growth of over 700 graduates. Alumni have collectively raised $10 billion in follow-on funding and introduced 400+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow them on LinkedIn, and subscribe to its monthly newsletter.
SOURCE RIVANNA
Regional program delivers double-digit sales growth, improved service performance, and expanded diagnostic access across Latin…
Four new products available now to put full diagnostics in the palm of technician's handsSPARKS,…
Global leaders, entrepreneurs and innovators will converge across the Tampa Medical & Research District and…
IPSWICH, Mass., Feb. 6, 2026 /PRNewswire/ -- New England Biolabs (NEB ®) will present several…
PLEASANTON, Calif., Feb. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"),…
NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Rokt, the leading ecommerce technology company using machine learning…